E-LIB Suche - Ergebnisse für: Pires da Silva, Inês

1

First-line chemoimmunotherapy and immunotherapy in patients..:

Brown, Lauren Julia ; Khou, Victor ; Brown, Chris...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Exploiting temporal aspects of cancer immunotherapy:

Zemek, Rachael M. ; Anagnostou, Valsamo ; Pires da Silva, Inês..
Nature Reviews Cancer. , 2024

Link: https://doi.org/10.1038/..

3

Anti-PD-1 alone or in combination with anti-CTLA-4 for adva..:

Pires da Silva, Ines ; Li, Isabel ; Ugurel, Selma...
European Journal of Cancer. 205 (2024) - p. 114101 , 2024

Link: https://doi.org/10.1016/..

4

Seasonal patterns of toxicity in melanoma patients treated ..:

Rogiers, Aljosja ; Dimitriou, Florentia ; Lobon, Irene...
European Journal of Cancer. 198 (2024) - p. 113506 , 2024

Link: https://doi.org/10.1016/..

5

Brief Report: Real-World Toxicity and Survival of Combinati..:

McNamee, Nicholas ; Harvey, Catriona ; Gray, Lauren...
Journal of Thoracic Oncology. 19 (2024) 4 - p. 636-642 , 2024

Link: https://doi.org/10.1016/..

6

Radiotherapy improves survival in Non-small cell lung cance..:

Brown, Lauren Julia ; Ahn, Julie ; Gao, Bo...
JTO Clinical and Research Reports. , 2024

Link: https://doi.org/10.1016/..

7

Classification of the tumor immune microenvironment and ass..:

Adegoke, Nurudeen A ; Gide, Tuba N ; Mao, Yizhe...
Journal for ImmunoTherapy of Cancer. 11 (2023) 10 - p. e007144 , 2023

Link: https://doi.org/10.1136/..

8

Durability of response to immune checkpoint inhibitors in m..:

Weppler, Alison M. ; Da Meda, Laetitia ; Pires da Silva, Ines...
European Journal of Cancer. 183 (2023) - p. 109-118 , 2023

Link: https://doi.org/10.1016/..

9

Lag-3 expression and clinical outcomes in metastatic melano..:

Gide, Tuba N. ; Paver, Elizabeth C. ; Yaseen, Zarwa...
OncoImmunology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

10

BRAF mutation testing for patients diagnosed with stage III..:

Scolyer, Richard A. ; Atkinson, Victoria ; Gyorki, David E....
Pathology. 54 (2022) 1 - p. 6-19 , 2022

Link: https://doi.org/10.1016/..

11

Higher proportions of CD39+ tumor-resident cytotoxic T cell..:

Attrill, Grace Heloise ; Owen, Carina N ; Ahmed, Tasnia...
Journal for ImmunoTherapy of Cancer. 10 (2022) 6 - p. e004771 , 2022

Link: https://doi.org/10.1136/..

12

Efficacy and safety of anti-PD1 monotherapy or in combinati..:

Pires da Silva, Ines ; Zakria, Danny ; Ahmed, Tasnia...
Journal for ImmunoTherapy of Cancer. 10 (2022) 7 - p. e004610 , 2022

Link: https://doi.org/10.1136/..

13

Real-world outcomes with ipilimumab and nivolumab in advanc..:

Serra-Bellver, Patricio ; Versluis, Judith M. ; Oberoi, Honey K....
European Journal of Cancer. 176 (2022) - p. 121-132 , 2022

Link: https://doi.org/10.1016/..

14

The effect of organ-specific tumor microenvironments on res..:

Conway, Jordan W. ; Braden, Jorja ; Wilmott, James S....
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

15

Unveiling the tumor immune microenvironment of organ-specif..:

Conway, Jordan W ; Rawson, Robert V ; Lo, Serigne...
Journal for ImmunoTherapy of Cancer. 10 (2022) 9 - p. e004884 , 2022

Link: https://doi.org/10.1136/..